Pharmaceutical Packaging Market

Pharmaceutical Packaging Market by Raw Material (Plastics, Paper & Paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Pre-filled syringes), Drug Delivery, and Region (2021 - 2026)

Report Code: CH 3482 Nov, 2022, by marketsandmarkets.com

[276 Pages Report] The global pharmaceutical packaging market size is estimated to be USD 99.9 billion in 2021 and is expected to reach USD 196.8 billion by 2026, at a CAGR of 14.5% from 2021 to 2026. This growth is attributed to the increased demand for pharmaceutical packaging in pharmerging economies such as Brazil, Russia, India, and China. The demand for technologically advanced solutions, such as self-administered drug delivery devices, is on the rise in developed countries such as the US, the UK, Japan, Germany, and others. Moreover, rising healthcare expenses, and growing consumer awareness regarding healthier lifestyle is driving the market for pharmaceutical packaging.

Pharmaceutical Packaging Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 impact on Global Pharmaceutical packaging Market

Covid-19 pandemic had adverse effects on the global healthcare industry. Impact of COVID-19 pandemic on the pharmaceutical sector included demand changes, regulation adjustments, R&D process modifications, supply chain restructuring, and the shift towards tele-consulting and tele-medicine. In addition, trends such as industry slow-down, approval delays, self-sufficiency in pharmaceutical production supply chain, modifying clinical trial methods, and variations in consumption of health & nutritional products could be some of the anticipated long-term impacts of COVID-19 pandemic on pharmaceutical sector at both global and local level.

Packaging activities were considered crucial during the COVID-19 pandemic. Pharmaceutical packaging companies gained from this and experienced stable revenue growth in 2020. Major pharmaceutical packaging companies had expanded their production to support the increased demand for pre-filled syringes, blister packs, vials, pouches, cartridges, bottles, and containers. This was mainly due to increased demand for Covid related vaccines and medications. In addition, pharmaceutical packaging for biologics, sterile packaging, smart packaging, patient focus packaging, cleanroom expansion, and others would drive the market in the long term.

Pharmaceutical packaging Market Dynamics

Driver: Growing demand for drug delivery devices and blister packaging

The demand for drug delivery devices and innovative packaging is increasing with the growing use of biologics and non-traditional administration routes such as nasal, transdermal, rectal, and IV. These systems have changed the market dynamics and have become as important as the drug itself. Growing preference for unit dosage packaging is further fueling the growth of this segment. The growing prevalence of chronic diseases, growth in biologics market, and technological advancements are expected to further drive the market for drug delivery and related packaging systems.

Blister packaging is gaining popularity owing to its ease of use. It is used for packaging of drugs as unit-dose packaging system. This packaging requires fewer resources to manufacture, provides compact packaging, has greater shelf life, better product visibility, easy handling, and availability at lower cost compared to rigid bottles, bags, etc. The growing over-the-counter medicine sale and increased level of product safety from contaminants such as moisture and oxygen are also driving the growth of this type of packaging. This type of packaging is easier to use and can also be customized according to patient requirements.

Restrain: Lack of access to proper healthcare

According to a WHO report, nearly half of the global population is unable to afford required healthcare services. In 2017, around 800 million spent at least 10% of their household budget in health expenses which reduced their household income to near poverty, as per findings by Global Monitoring Report.

Poverty is a major barrier to accessing healthcare facilities in these emerging economies. Financial constraints, lack of information, outdated equipment, lack of proper staff, and awareness of proper healthcare practices are the major challenges that limit the access to healthcare services. These issues together restrain the growth of the pharmaceutical packaging market in emerging regions such as India, Brazil, South Africa, and others. However, better government policies and strict implementation of regulations will boost the market in the next five years.

Opportunity: Growing demand for primary pharmaceutical packaging

Rise of advanced and diverse drug producing companies in developed economies such as the US, Japan, Canada, Germany, France, and the UK and growth in use of advanced packaging technologies such as patient specific dosages, eco-friendly packaging, and innovative counterfeiting techniques will drive the growth for primary packaging. Furthermore, India, Russia, Turkey, Mexico, Argentina, and China are expected to become some of the fastest growing markets owing to rapidly expanding pharmaceutical manufacturing capabilities and adoption of more stringent regulations intended at improving the quality and reliability of domestically produced drugs.

Challenge: Safeguarding against counterfeit products

Counterfeit drugs are made with incorrect ingredients in improper quantities, which when consumed would result in dangerous effects such as allergic reactions or sometimes death. Anti-malarial and antibiotics are among the most commonly counterfeited medical products. Nearly half of the counterfeit drugs are reported in developing economies such as China, Vietnam, and the Philippines. These counterfeit products have negative effects on the human body, in terms of allergic reactions, vomiting, nausea, and others. Safeguarding against these counterfeit products is a major challenge for the sector.

Pharmaceutical Packaging Market: Value Chain Analysis

Pharmaceutical Packaging Market by Value Chain Analysis

Plastics is projected to be the fastest growing raw material segment in the pharmaceutical packaging market

Plastic offers freedom of design and cost-effective solution, making it a highly compatible solution for pharmaceutical packaging. The plastics & polymers segment dominates the overall pharmaceutical packaging market. HDPE is the most widely used material in the plastics & polymers segment. The market for this segment is driven by the increasing demand for plastic bottles, medical specialty bags, and other pharmaceutical packaging components made of plastic or polymer.

Pre-filled syringes is expected to witness fastest growth in the pharmaceutical packaging market during the forecast period.

Prefilled syringes are prepacked single dose unit of drugs in which the needle has been fixed. Prefilled syringes provide advantages such as minimal drug wastage, increased product lifespan, enhanced protection, ease of use, reliable, sterility, self-medication features, and others. These packaging are convenient and ease the administration process to patients. These systems reduce patient exposure to toxic substance and decrease needle sticks.

Oral is anticipated to be the largest pharmaceutical packaging drug delivery mode in 2021.

Oral drug delivery is the most preferred administration route for any drug owing to its noninvasiveness, high patient compliance, convenience of handling, and non-requirement of any specific sterile conditions. Oral drug delivery mode is anticipated to be the largest category in the overall pharmaceutical packaging market. This large market size can be attributed to the convenience in usage, increased incidence of chronic diseases, improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, and heavy investments made by big pharmaceutical players for enhancing in-house capabilities to develop oral drug delivery technologies.

APAC is expected to witness fastest growth in the pharmaceutical packaging market during the forecast period.

APAC is forecasted to be the fastest-growing region in the pharmaceutical packaging market in 2020. The recent trends toward improved healthcare systems and access to healthcare services in APAC could offer the pharmaceutical packaging providers new opportunities for growth in the region. The pharmerging market of the APAC region is expected to witness the fastest growth in the coming years due to increasing government initiatives, growing population, changing lifestyle, growing contract manufacturing activities, and the aging population. Increasing government initiatives in emerging pharmaceutical market, increase in contract manufacturing activities, rise in aging population, and increased spending on healthcare are driving the market in APAC. Japan, China, Australia, India, and South Korea are the major markets in this region. In addition, growing technological advancements in healthcare sector in countries such as China, Singapore, Malaysia, Thailand, and others, increasing urbanization, and changing lifestyle are also some of the driving factors for the market growth in pharmaceutical packaging industry.

Pharmaceutical Packaging Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

The key players in the pharmaceutical packaging market include Berry Global (US), Catalent (US), Schott AG (Germany), West Pharmaceutical Services, Inc. (US), WestRock (US), Aptar Group (US), Gerresheimer AG (Germany), and Amcor (Switzerland). The pharmaceutical packaging market report analyzes the key growth strategies, such as new product launches, investments & expansions, joint ventures, agreements, partnerships, and mergers & acquisitions adopted by the leading market players between 2018 and 2021.

Pharmaceutical Packaging Market Report Scope

Report Metric

Details

Market Size Value in 2021

USD 99.9 billion

Revenue Forecast in 2026

USD 196.8 billion

CAGR

14.5%

Years considered for the study

2019–2026

Base year considered

2020

Forecast period

2021–2026

Units considered

Volume (Kiloton) and Value (USD)

Segments

Raw Material, Types, Drug Delivery Modes, and Region

Regions

North America, APAC, Europe, Middle East & Africa, and South America

Companies

Schott AG (Germany), Amcor (Switzerland), Aptar Group (US), West Pharmaceutical Services, Inc. (US), Berry Global (US), Gerresheimer AG (Germany), Catalent (US), and WestRock (US)
25 major players covered.

This research report categorizes the pharmaceutical packaging market based on raw material, types, drug delivery modes, and region.

By Material:

By Drug Delivery:

  • Oral Drugs
  • Injectables
  • Topical
  • Ocular/ Ophthalmic
  • Nasal
  • Pulmonary
  • Transdermal
  • IV Drugs
  • Others
  • Others

By Type:

  • Plastic bottles
  • Blister
  • Labels & accessories
  • Caps & closures
  • Pre-filled syringes
  • Medical specialty bags
  • Temp controlled packaging
  • Pouches & strip packs
  • Pre-filled inhalers
  • Vials
  • Ampoules
  • Medication tubes
  • Jars & Canisters
  • Cartriges
  • Others

By Region:

  • North America
  • APAC
  • Europe
  • Middle East & Africa
  • South America

The pharmaceutical packaging market has been further analyzed based on key countries in each of these regions.

Recent Developments

  • In May 2021, Gerresheimer introduced a new platform for on body infusion pump “SensAIR”, that can deliver drugs of high viscosity. It is easy to use and helps in self determination of medication.
  • In February 2020, Berry Global introduced new oval tube, extruded, formed and decorated at facility in United States. These oval tubes are suitable for variety of products other than healthcare such as beauty and personal care or homecare.
  • In April 2019, Amcor launched a new product named AmLite Ultra Recyclable. This revolutionary product is expected to provide the advantage of a reduced carbon footprint. It is available in various forms such as pillow pouches, stick packs, and bags. The product is certified for recyclability by cyclos-HTP Institute.
  • In August 2018, Schott announced it expected to increase production capacity of polymer syringes with volume size 1–50 ml, by 2020. This production line will be installed in Switzerland. The company will be able to serve the increasing demand for polymer syringes through this expansion.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 SCOPE OF THE STUDY
    1.4 CURRENCY
    1.5 PACKAGE SIZE
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES
    1.8 INCLUSIONS & EXCLUSIONS 

2 RESEARCH METHODOLOGY
    2.1 RESEARCH DATA
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Breakdown of primary interviews
    2.2 MARKET SIZE ESTIMATION
           2.2.1 BOTTOM-UP APPROACH
           2.2.2 TOP-DOWN APPROACH
    2.3 DATA TRIANGULATION
    2.4 MARKET SIZE ESTIMATION
    2.5 FORECAST ESTIMATION
    2.6 RESEARCH ASSUMPTIONS
    2.7 LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
    4.1 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL
    4.2 PHARMACEUTICAL PACKAGING MARKET, BY TYPE
    4.3 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY
    4.4 PHARMACEUTICAL PACKAGING MARKET GROWTH RATE, BY COUNTRY

5 MARKET OVERVIEW
    5.1 INTRODUCTION
    5.2 MARKET SEGMENTATIONS
    5.3 MARKET DYNAMICS
           5.3.1 DRIVERS
           5.3.2 RESTRAINTS
           5.3.3 OPPORTUNITIES
           5.3.4 CHALLENGES

6 INDUSTRY TRENDS
    6.1 INTRODUCTION
    6.2 VALUE CHAIN ANALYSIS
           6.2.1 RAW MATERIAL
           6.2.2 EQUIPMENT MANUFACTURERS
           6.2.3 DISTRIBUTORS
           6.2.4 END-USERS
    6.3 PORTER’S FIVE FORCES ANALYSIS
           6.3.1 THREAT OF SUBSTITUTES
           6.3.2 BARGAINING POWER OF BUYERS
           6.3.3 THREAT OF NEW ENTRANTS
           6.3.4 BARGAINING POWER OF SUPPLIERS
           6.3.5 INTENSITY OF COMPETITIVE RIVALRY
    6.4 PATENT ANALYSIS
    6.5 PRICING ANALYSIS
           6.5.1 AVERAGE SELLING PRICES OF KEY PLAYERS
    6.6 ECOSYSTEM/ MARKET MAPPING
    6.7 TECHNOLOGY ANALYSIS
    6.8 KEY CONFERENCES AND EVENTS
    6.9 TARRIF AND REGULATORY LANDSCAPE
           6.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    6.10 KEY STAKEHOLDERS AND BUYING CRITERIA
    6.11 CASE STUDIES

7 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL
    7.1 INTRODUCTION
    7.2 PLASTICS
    7.3 PAPER & PAPERBOARD
    7.4 GLASS
    7.5 METALS
    7.6 OTHER

8 PHARMACEUTICAL PACKAGING MARKET, BY TYPE
    8.1 INTRODUCTION
    8.2 PLASTIC BOTTLES 
    8.3 BLISTER PACKS
    8.4 LABELS & ACCESSORIES
    8.5 CAPS & CLOSURES
    8.6 MEDICAL SPECIALTY BAGS
    8.7 PRE-FILLED SYRINGES
    8.8 TEMPERATURE CONTROLLED PACKAGING
    8.9 POUCHES & STRIP PACKS
    8.10 AMPOULES
    8.11 VIALS
    8.12 PRE-FILLED INHALERS
    8.13 MEDICATION TUBES
    8.14 JARS & CANISTERS
    8.15 CARTRIDGES
    8.16 OTHERS

9 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY
    9.1 INTRODUCTION
    9.2 ORAL DRUG DELIVERY PACKAGING
    9.3 PULMONARY DRUG DELIVERY PACKAGING
    9.4 TRANSDERMAL DRUG DELIVERY PACKAGING
    9.5 INJECTABLE PACKAGING
    9.6 TOPICAL DRUG DELIVERY PACKAGING
    9.7 NASAL DRUG DELIVERY PACKAGING
    9.8 OCULAR DRUG DELIVERY PACKAGING
    9.9 IV DRUG DELIVERY PACKAGING
    9.10 OTHER DRUG DELIVERY PACKAGING

10 PHARMACEUTICAL PACKAGING MARKET, BY REGION
     10.1 INTRODUCTION
     10.2 ASIA-PACIFIC
             10.2.1 CHINA
             10.2.2 JAPAN
             10.2.3 INDIA
             10.2.4 SOUTH KOREA
             10.2.5 AUSTRALIA
             10.2.6 REST OF APAC
     10.3 NORTH AMERICA
             10.3.1 U.S
             10.3.2 CANADA
             10.3.3 MEXICO
     10.4 EUROPE
             10.4.1 GERMANY
             10.4.2 U.K
             10.4.3 FRANCE
             10.4.4 SPAIN
             10.4.5 ITALY
             10.4.6 REST OF EUROPE
     10.5 MIDDLE-EAST & AFRICA
             10.5.1 SAUDI ARABIA
             10.5.2 SOUTH AFRICA
             10.5.3 UAE
             10.5.4 REST OF MEA
     10.6 SOUTH AMERICA
             10.6.1 BRAZIL
             10.6.2 ARGENTINA
             10.6.3 REST OF SOUTH AMERICA

11 COMPETITIVE LANDSCAPES
     11.1 OVERVIEW
             11.1.1 KEY PLAYER STRATEGIES/ RIGHT TO WIN
             11.1.2 OVERVIEW OF STRATEGIES DEPLOYED
     11.2 MARKET EVALUATION FRAMEWORK
     11.3 COMPANY REVENUE ANALYSIS
     11.4 MARKET SHARE/RANKING OF KEY PLAYERS
     11.5 COMPETITIVE SITUATION AND TRENDS
             11.5.1 NEW LAUNCHES
             11.5.2 DEALS
             11.5.3 JVS/ TECHNLOLOGIAL COLLABORATIONS

12 COMPANY PROFILES*
((Business Overview, Financials**, Products Offered, Scorecard of Product Offering, Scorecard of Business Strategy, and Recent Developments)
     12.1 BERRY GLOBAL INC.
             12.1.1 Business overview
             12.1.2 Products offered
             12.1.3 Recent Developments
             12.1.4 MnM view
                        12.1.4.1 Key strengths/right to win
                        12.1.4.2 Strategic choices made
                        12.1.4.3 Weaknesses and competitive threats
     12.2 GERRESHEIMER AG
     12.3 AMCOR PLC
     12.4 SCHOTT AG
     12.5 APTARGROUP, INC.
     12.6 BECTON, DICKINSON AND COMPANY
     12.7 CATALENT, INC.
     12.8 NIPRO CORPORATION
     12.9 WEST PHARMACEUTICAL SERVICES, INC.
     12.10 WESTROCK
     12.11 OTHER COMPANIES

The study involved four major activities in estimating the current market size for pharmaceutical packaging. The exhaustive secondary research was conducted to collect information on the market, peer market, and child market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, the market breakdown and data triangulation methodologies were used to estimate the market size of segments and sub-segments.

Secondary Research

In the secondary research process, various secondary sources such as Bloomberg, World Bank, Statista, European Medical Agency, Packaging Industry Associations, Trademap, Zauba, were referred to for identifying and collecting information for this study. These secondary sources included annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, regulations form agencies such as the Food & Drug Administration, World Health organization (WHO), The European Federation of Pharmaceutical Industries and Associations (EFPIA), Pharmaceuticals Export Promotion Council of India, regulatory bodies, and databases.

Primary Research

The pharmaceutical packaging market comprises several stakeholders such as raw material suppliers, distributors of pharmaceutical packaging, end-users, and regulatory organizations in the supply chain. The demand side of this market consists of pharmaceutical drug manufacturers, medical drug filling contractors, hospitals, labs, research institutes, and other healthcare institutions. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.

Following is the breakdown of primary respondents

Pharmaceutical Packaging Market  Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the pharmaceutical packaging market. These methods were also used extensively to estimate the size of various sub-segments in the market. The research methodology used to estimate the market size includes the following:

  • The key players, raw material, types, and drug delivery modes in the industry and markets were identified through extensive secondary research.
  • The industry’s supply chain and market size, in terms of value and volume, were determined through primary and secondary research processes.
  • All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the overall market size—using the market size estimation process explained above—the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply of pharmaceutical packaging and their applications.

Objectives of the Study:

  • Analyze and forecast size of the pharmaceutical packaging market in terms of value and volume.
  • To provide detailed information about the key factors (drivers, restraints, opportunities, and challenges) influencing the market
  • To analyze and forecast the market by type, by raw material, drug delivery, and region.
  • To forecast the size of the market with respect to five regions: Asia Pacific (APAC), Europe, North America, South America, and the Middle East & Africa, along with their key countries
  • To strategically analyze micro markets1 with respect to individual trends, growth prospects, and their contribution to the overall market
  • To analyze opportunities in the market for stakeholders and provide a competitive landscape for market leaders.
  • Analyze competitive developments such as mergers & acquisitions, new product developments, investments & expansions, and agreements & partnerships in the pharmaceutical packaging market
  • Strategically profile key players and comprehensively analyze their market shares and core competencies2.

Notes: 1. Micro markets are defined as sub segments of the pharmaceutical packaging market included in the report.
2. Core competencies of the companies are covered in terms of their key developments and strategies adopted to sustain their position in the market.

Available Customizations:

With the given market data, MarketsandMarkets offers customizations according to the specific requirements of companies. The following customization options are available for the report:

Regional Analysis:

  • Country-level analysis of the pharmaceutical packaging market

Company Information:

  • Detailed analysis and profiling of additional market players
Report Code
CH 3482
Published ON
Nov, 2022
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Pharmaceutical Packaging Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback